Today: 7 February 2026
Subscribe
Browse Category

NYSE:HUM News 7 January 2026 - 7 February 2026

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth shares rose 3.4% to $277.57 Friday and gained another 3% after hours, rebounding after a volatile week for health insurers. Mizuho cut its price target on the stock to $350, citing delayed earnings recovery. Medicare Advantage rates and medical-cost trends remain key concerns. The Dow closed above 50,000, marking the strongest market gains in months.
7 February 2026
····
UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth shares fell nearly 3% to $275.92 in after-hours trading Wednesday after the FTC announced a 10-year insulin pricing settlement with Cigna’s Express Scripts, increasing scrutiny on OptumRx and CVS Caremark. Investors are watching for an FTC oral argument Feb. 5 and a House hearing on drug prices Feb. 11. CVS and Cigna shares also declined. UnitedHealth did not comment.
5 February 2026
·····
UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth shares rose 1% to $289.75 Monday, outperforming peers as Humana, Elevance, and Cigna declined. Truist and JPMorgan cut price targets but kept positive ratings. Investors focused on Medicare Advantage payment rates and 2026 cost trends after last week’s sector sell-off. Final 2027 Medicare Advantage rates are expected in April.
2 February 2026
·······
UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth shares fell 0.6% to $292.29 in after-hours trading Thursday after the U.S. Labor Department proposed new disclosure rules for pharmacy benefit managers. The proposal would require PBMs to reveal fee and compensation details. Investors are also closely watching upcoming Medicare Advantage rate decisions. Related health insurer stocks showed mixed movement late Thursday.
30 January 2026
·····
Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health shares rose 1% to $345.44 Thursday, leading gains in managed-care stocks after policy and earnings volatility. The company forecast 2026 adjusted EPS of at least $25.50, below analyst expectations, and warned of revenue declines amid Medicaid and ACA headwinds. Medicare Advantage payments are set for a minimal 0.09% increase in 2027, rattling the sector. ACA enrollment for 2026 dropped to about 23 million as subsidies ended.
29 January 2026
·····
Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

The Dow rose 49.62 points to 49,053.03 by midday Wednesday as the S&P 500 briefly topped 7,000 before retreating. Intel jumped 11.3%, while UnitedHealth plunged nearly 20% after the Trump administration proposed a 0.09% Medicare Advantage rate hike for 2027. The Fed is expected to hold rates steady. Seagate surged 19.3% on earnings.
28 January 2026
·······
Dow Jones today: Dow hovers near 49,000 as Fed decision and mega-cap earnings loom

Dow Jones today: Dow hovers near 49,000 as Fed decision and mega-cap earnings loom

The Dow Jones hovered near 49,000 Wednesday morning, dipping 3.56 points to 48,999.85 as UnitedHealth’s sharp fall continued to weigh on the index. The S&P 500 briefly topped 7,000, boosted by chip stocks after upbeat results from ASML and SK Hynix. The Federal Reserve’s policy decision is due at 2 p.m. EST. Meta, Microsoft, Tesla, and IBM report earnings after the bell.
28 January 2026
···········
Dow Jones today: Dow futures inch up as Fed decision and Big Tech earnings loom

Dow Jones today: Dow futures inch up as Fed decision and Big Tech earnings loom

Dow futures rose about 30 points ahead of the Fed’s policy decision, with S&P 500 and Nasdaq 100 futures also up. Health insurers slumped after U.S. officials proposed a 0.09% Medicare Advantage payment hike, far below expectations. The Dow fell 409 points Tuesday, dragged by UnitedHealth, Humana, and CVS losses, while the S&P 500 and Nasdaq hit records on tech gains. Microsoft and Meta will report earnings Wednesday.
28 January 2026
·····
Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana shares fell 21.1% to $207.93 in after-hours trading Tuesday after the Centers for Medicare & Medicaid Services proposed a 0.09% average payment increase for Medicare Advantage in 2027, far below analyst expectations. The draft also included stricter rules on diagnosis data. U.S. health insurer stocks dropped sharply, erasing billions in market value. Comments on the proposal are due by Feb. 25.
28 January 2026
··
UnitedHealth Group stock price tumbles: UNH slides nearly 20% after outlook, Medicare Advantage rates in focus

UnitedHealth Group stock price tumbles: UNH slides nearly 20% after outlook, Medicare Advantage rates in focus

UnitedHealth Group shares fell 19.5% to $282.90 in after-hours trading Tuesday after a weak Medicare Advantage rate proposal from the Trump administration. The company expects to lose up to 1.4 million Medicare Advantage members in 2026 and forecasts a drop in Medicaid membership. CVS and Humana shares also plunged. The government’s final Medicare Advantage rate decision is due April 6.
27 January 2026
···
UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors

UnitedHealth shares fell 18.4% to $286.96 Tuesday after a U.S. proposal signaled Medicare Advantage payments would rise just 0.09% in 2027. The company warned of its first revenue drop since 1989 despite maintaining its 2026 profit outlook. CVS Health and Humana also posted sharp declines. CMS will accept comments on the proposed rates through Feb. 25.
27 January 2026
···
Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

The Dow Jones fell 445 points, or 0.9%, to 48,966 in early trading, dragged down by a 20% plunge in UnitedHealth after weak Medicare payment proposals and a downbeat 2026 forecast. U.S. consumer confidence dropped to its lowest since 2014. The S&P 500 and Nasdaq rose, while Humana and CVS also tumbled. Traders watched for earnings and the Fed meeting starting Tuesday.
27 January 2026
···
Why UnitedHealth stock fell today: UNH slides as Medicare Advantage spotlight returns

Why UnitedHealth stock fell today: UNH slides as Medicare Advantage spotlight returns

UnitedHealth shares fell 2.3% to $331.02 in after-hours trading Friday following a MedPAC report highlighting $76 billion in projected Medicare Advantage overpayments. The drop came ahead of a long holiday weekend and the company’s earnings release set for Jan. 27. Managed-care stocks broadly declined, with Humana down 3.76% and Elevance Health off 1.85%.
17 January 2026
···
UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth shares fell 1.3% to $334.40 Friday, weighing on the Dow as managed-care stocks slid after Trump’s new healthcare proposal. The plan, which would replace insurance subsidies with direct payments to consumers, left policy details unclear and insurers under pressure. UnitedHealth will report 2025 earnings and its 2026 outlook on Jan. 27. Investors are watching for updates on government-plan costs and future guidance.
16 January 2026
······
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth shares fell over 2% to $340.44 Wednesday morning, erasing part of Tuesday’s gain. The drop followed analyst moves, with Bernstein raising its target to $444 and Evercore ISI starting coverage at $400. Investors await UnitedHealth’s Jan. 27 results and Medicare Advantage rate updates. Humana and Cigna also declined.
7 January 2026
·······
1 2

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop